Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Fennec Pharmaceuticals Inc. (FENC - Free Report) develops product candidates for use in the treatment of cancer in the United States. The Zacks Consensus Estimate for its current year earnings has been revised 5% downward over the last 30 days.
American Vanguard Corporation (AVD - Free Report) is a developer and manufacturer of specialty chemicals for agricultural, commercial, and consumer uses. The Zacks Consensus Estimate for its current year earnings has been revised 8.5% downward over the last 30 days.
Cortexyme, Inc. is focussed on developing therapeutics for Alzheimer's disease and other degenerative disorders. The Zacks Consensus Estimate for its current year earnings has been revised 6.3% downward over the last 30 days.
Elbit Systems Ltd. (ESLT - Free Report) is a supplier of a range of airborne, land, and naval systems and products. The Zacks Consensus Estimate for its current year earnings has been revised 1.4% downward over the last 30 days.
New Relic, Inc. is a software-as-a-service company. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Fennec Pharmaceuticals Inc. (FENC - Free Report) develops product candidates for use in the treatment of cancer in the United States. The Zacks Consensus Estimate for its current year earnings has been revised 5% downward over the last 30 days.
American Vanguard Corporation (AVD - Free Report) is a developer and manufacturer of specialty chemicals for agricultural, commercial, and consumer uses. The Zacks Consensus Estimate for its current year earnings has been revised 8.5% downward over the last 30 days.
Cortexyme, Inc. is focussed on developing therapeutics for Alzheimer's disease and other degenerative disorders. The Zacks Consensus Estimate for its current year earnings has been revised 6.3% downward over the last 30 days.
Elbit Systems Ltd. (ESLT - Free Report) is a supplier of a range of airborne, land, and naval systems and products. The Zacks Consensus Estimate for its current year earnings has been revised 1.4% downward over the last 30 days.
New Relic, Inc. is a software-as-a-service company. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ESLT - FREE
Get the latest research report on AVD - FREE
Get the latest research report on FENC - FREE